Published on
September 2, 2025
- 12:00 GMT
FDA Expands MagVenture TMS Indications to Treat MDD, OCD, and Anxious Depression with One Coil
ALPHARETTA, GA, UNITED STATES, September 2, 2025 /EINPresswire.com/ -- MagVenture®, the global leader in non-invasive TMS therapy, announces FDA clearance expanding the indications for its MagVenture TMS Therapy™ system to include treatment of Major …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Science
...
